In clinical phase II studies. the efficacy of a promising therapy is tested in patients for the first time. Based on the results. it is decided whether the development programme should be stopped or whether the benefit-risk profile is promising enough to justify the initiation of large phase III studies. https://www.hindigyanvishv.com/super-find-Red-Pygmy-reg-Dogwood-Tree-limited-super/